Zyprexa

• Drug maker Eli Lilly to cut 1,000 US sales jobs: report

  Drug maker Eli Lilly and Co plans to lay off about 1,000 domestic sales representatives, or 30 per cent of its US sales force, as it faces new generic competition for its top drugs, a person familiar with the matter said on Friday.

• Sun Pharma gets US regulator nod for generic schizophrenia tablets

  The company said US Food and Drug Administration (USFDA) has granted approval for its abbreviated new drug application (ANDA) for generic version of Zyprexa Zydis, Olanzapine ODT, in strengths of 5 mg, 10 mg, 15 mg and 20 mg, Sun Pharma said in a statement.

• USFDA approves first generic version of Zyprexa

  US Food and Drugs Administration has approved the generic version of Zyprexa. US patent on Zyprexa (Eli Lilly’s USD2.5b brand in US) had expired on October 23. Dr. Reddy's Lab (DRL) and Teva Pharmaceutical Industries have joined hands to launch a generic version of the drug with an exclusivity period of 180 days. DRL will be eligib...

• Dr. Reddy`s Laboratories launches generic Zyprexa in the US

  Based on IMS sales data, annual sales of Zyprexa were approximately $3.2 billion in the United States as of September 2011